Dimensional Fund Advisors
CRBP icon

Dimensional Fund Advisors’s Corbus Pharmaceuticals CRBP Stock Holding History

Dimensional Fund Advisors’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.78M Buy
190,214
+53,612
+39% +$508K ﹤0.01% 2762
2026
Q1 		$1.28M Buy
136,602
+59,248
+77% +$499K ﹤0.01% 2794
2025
Q4 		$630K Buy
+77,354
New +$955K ﹤0.01% 2934
2025
Q1 		– Sell
-16,075
Closed -$190K – 3334
2024
Q4 		$190K Hold
16,075
– – ﹤0.01% 3171
2024
Q3 		$332K Hold
16,075
– – ﹤0.01% 3096
2024
Q2 		$727K Hold
16,075
– – ﹤0.01% 2962
2024
Q1 		$631K Sell
16,075
-617
-4% -$15.2K ﹤0.01% 3001
2023
Q4 		$101K Sell
16,692
-12,531
-43% -$67.3K ﹤0.01% 3278
2023
Q3 		$197K Sell
29,223
-2,377
-8% -$16.5K ﹤0.01% 3222
2023
Q2 		$248K Buy
31,600
+17,919
+131% +$161K ﹤0.01% 3200
2023
Q1 		$99.5K Buy
+13,681
New +$59.9K ﹤0.01% 3301
2022
Q1 		– Sell
-1,052
Closed -$19K – 3522
2021
Q4 		$19K Hold
1,052
– – ﹤0.01% 3530
2021
Q3 		$32K Sell
1,052
-1,141
-52% -$45K ﹤0.01% 3489
2021
Q2 		$120K Buy
+2,193
New +$122K ﹤0.01% 3394

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Dimensional Fund Advisors's CRBP Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Corbus Pharmaceuticals (CRBP) stake by 39% in Q2 2026, buying an estimated $508K and bringing the position to 190,214 shares worth $1.78M. The position accounts for ﹤0.01% of the portfolio, ranked #2762.

Dimensional Fund Advisors first reported a position in CRBP in Q2 2021 and has held it in 14 quarters since. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • Dimensional Fund Advisors held 190,214 shares of Corbus Pharmaceuticals worth $1.78M as of Q2 2026.
  • Dimensional Fund Advisors bought 53,612 Corbus Pharmaceuticals shares in Q2 2026, an estimated $508K.
  • Corbus Pharmaceuticals made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2762 holding.
  • Dimensional Fund Advisors first reported a position in Corbus Pharmaceuticals in Q2 2021 and has held it in 14 quarters since.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.